What to watch with Östradiol and Langlebigkeit?

The question of estradiol and longevity is complex and poorly addressed by direct-to-consumer (DTC) tests like MyBody-X. Estradiol, the primary estrogen in women, influences bone density, cardiovascular health, and cognitive function—all factors linked to longevity. However, evidence for a causal relationship between estradiol levels and extended lifespan is weak and conflicting. Hormone replacement therapy (HRT) during menopause carries risks such as breast cancer and thrombosis, while low estradiol is associated with osteoporosis and cardiovascular issues. DTC hormone tests typically measure a single time point, which is highly cycle-dependent and cannot predict long-term effects. Moreover, the provided context lacks specific markers or studies on estradiol and longevity. Such test results should be considered screening-level, not diagnostic or prognostic. For longevity optimization, validated biomarkers like HbA1c, LDL cholesterol, vitamin D, and inflammatory markers are more relevant, and medical consultation is essential. Evidence grade: marketing/unclear. Sources: none in context.